Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
Part of paid clinical trials in The Villages, Florida.
- Sponsor
- Amgen
- Study ID
- NCT07871409
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Maridebart cafraglutide — DRUGAdministered subcutaneously.
- Autoinjector — DEVICEThe AI will be used by participants to self-administer SC doses of maridebart cafraglutide.
Study Details
The main objective of this study is to assess participants' ability to self-administer subcutaneous doses of maridebart cafraglutide at home using an autoinjector device.
Key Dates
- First listed
- Oct 13, 2026
- Start date
- Oct 28, 2026
- Status verified
- Oct 2026
- Primary completion
- Jun 16, 2027
- Completion
- Sep 8, 2027
Study Design
- Enrollment
- 230 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Maridebart cafraglutideParticipants will receive 8 total doses of subcutaneous (SC) injections of maridebart cafraglutide.
Primary Outcome Measure
Percentage of Participants Who Successfully Self-inject a Full Dose Among Those Who Attempted Injection at Each Home Administration [ Time Frame: Weeks 12, 16, and 20 ]
Central Contacts
- Amgen Call Center866-572-6436
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Charter Research - The Villages | The Villages | Florida | 32162 | - |
Find similar trials in The Villages, FL
By condition
By specialty
By research site
Related Studies
- Modifying Diet to Improve Gut MicrobiomeNot Yet Recruiting · H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida
- Microvascular Dysfunction in ObesityRecruiting · Florida State University · Tallahassee, Florida
- The RESET System Pivotal Clinical Trial (Protocol Revision K)Recruiting · Morphic Medical Inc. · Gilbert, Arizona
- Exercise Training and Fat Metabolism in Postmenopausal WomenRecruiting · Florida State University · Tallahassee, Florida